Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: we did hear some good things from share holder meeting..
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Re: "lowered expenses by 25% ... PDSG had a 1 million in work ..."

Yes, this is good news, but ... we need in the range of $50 million annually to make 10 cents a share. That's $50 million after splitting revenue with TPL and after all expenses. Unfortunately, looking at the net impact to the bottom line, and the big picture, this good news is like spit on a forest fire.

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply